Rachel Kramer

Principal

The Moran Company

Washington, DC

[javascript protected email address]

Rachel Kramer has over 20 years of health policy analysis and consulting experience with a focus on accurate coding, coverage, and reimbursement for new products and services to facilitate beneficiary access through stable and appropriate payments. By combining subject matter expertise with results from quantitative evaluations, she can support strategic and tactical planning and provide recommendations for clients to navigate the current landscape as well as anticipate and respond to emerging policy dynamics. 

Prior to joining HMA, Rachel was a partner at The Moran Company (TMC), now an HMA company. At HMA, Rachel continues her work to help organizations representing the industry and providers understand, assess, and quantify the implications of Medicare payment policy proposals on clinical or business priorities. She works with clients to develop recommendations and roadmaps for the valuation of new technologies and has assisted clients with policy development and/or analysis in areas of imaging and diagnostics, remote monitoring, digital health and artificial intelligence, vaccines, physician administered drugs, novel therapies for cancer, ophthalmology, and behavioral health, as well as physician and other qualified healthcare professionals.  

Rachel’s experience in consulting, associations, provider settings and in health information management lend to her ability to engage professionals of different disciplines and across policy topics to help organizations respond to opportunities and threats that arise from policy and market changes. She routinely provides health policy briefings, historical perspective, subject matter expertise and technical assistance to stakeholders and their representatives as they navigate federal legislative and regulatory processes, including comment letter development, payment reform considerations and executive branch interactions. 

Rachel leads the TMC physician services team and oversees TMC modeling initiatives such as the company’s replication of the Centers for Medicare and Medicaid Services (CMS) Practice Expense (PE) Relative Value Unit (RVU) methodology. Rachel also assists clients with claims data analysis to study patient populations or trends in utilization and spending. 

Before joining TMC, Rachel was the director of economics and health policy for a national medical specialty society, was a consultant with a national firm, and worked in the hospital system and freestanding clinic settings. 

Rachel has a Master of Public Health with a concentration in policy and finance from the Johns Hopkins Bloomberg School of Public Health and is credentialed as a Registered Health Information Administrator (RHIA). She also has a bachelor’s degree in health information management from the University of Pittsburgh.